-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
-
Summary
-
Rapport Therapeutics, Inc. quarterly Common Stock, Value, Issued history and growth rate from Q4 2023 to Q3 2024.
- Rapport Therapeutics, Inc. Common Stock, Value, Issued for the quarter ending September 30, 2024 was $36K.
Common Stock, Value, Issued, Quarterly (USD)